Rocket Doctor AI Secures SOC 2 Type I Certification, Enhancing Trust with Enterprise Healthcare Partners

Understanding SOC 2 Type I Compliance and Its Impact on Rocket Doctor's Security Framework

SOC 2 Type I, developed by the American Institute of Certified Public Accountants (AICPA), is a widely recognized auditing standard that evaluates how organizations safeguard sensitive customer data. Unlike SOC 2 Type II, which measures operational effectiveness over a period, Type I assesses whether controls are properly designed and implemented at a specific moment. Successfully passing this audit confirms that an independent third party has validated Rocket Doctor’s security infrastructure as appropriately structured to protect sensitive information.

The independent audit examined Rocket Doctor’s information security, access management, data privacy, confidentiality controls, incident response, business continuity planning, risk management, governance, and secure system development and change management. The findings confirmed these controls are well designed and implemented throughout the organization, offering stakeholders an externally verified snapshot of the company’s security posture.

Eight Months of Focused Investment in Compliance Initiatives

Rocket Doctor dedicated substantial resources over eight months to achieve SOC 2 Type I compliance as part of its broader enterprise growth strategy. Since inception, the company has prioritized privacy and security, appointing dedicated privacy leadership and making significant investments in governance, cybersecurity, risk management, and compliance programs.

While the exact financial cost was not disclosed, the characterization of the investment as "substantial" over this period provides important context for investors evaluating the operational spending priorities of this growth-stage digital health company. These investments are framed as an ongoing commitment to responsible data stewardship rather than a one-time expense.

Insights from Harry Cherniak on Data Security as a Healthcare Technology Imperative

Harry Cherniak, co-founder, Chief Privacy Officer, and Chief Operating Officer of Rocket Doctor Inc., stated: "As healthcare increasingly relies on digital infrastructure, data security and compliance have become baseline requirements for technology adoption. Achieving SOC 2 Type I compliance validates the rigorous controls and processes we've built to safeguard patient and partner data."

Cherniak emphasized that this milestone "provides healthcare organizations, employers, payors, pharmacies, and government partners with independent assurance that Rocket Doctor meets the highest standards for security and operational integrity." This highlights the certification’s role as a commercial enabler, offering prospective partners the independent validation needed before adopting cloud-based digital health solutions at scale.

Certification’s Role in Advancing Rocket Doctor’s Enterprise Partnerships

Achieving SOC 2 Type I compliance enhances Rocket Doctor’s capability to support enterprise healthcare partners by delivering a validated security framework designed to simplify procurement and onboarding for large health systems, employers, insurers, and pharmacy networks. Many large organizations handling protected health information require vendors to demonstrate compliance with recognized security standards before contracting.

The announcement identifies healthcare organizations, employers, payors, pharmacies, and government partners as key stakeholders for whom this certification is most relevant. While this removes a common procurement hurdle and could accelerate commercial opportunities, no specific new contracts or partnerships were disclosed as a direct result of this achievement. Investors should note that certification alone does not guarantee new business.

Progressing Toward SOC 2 Type II Certification

Following SOC 2 Type I certification, Rocket Doctor has commenced work on SOC 2 Type II compliance. Unlike Type I, which assesses controls at a point in time, Type II evaluates the operational effectiveness of controls over a sustained period, typically six months or more. Achieving Type II certification is generally viewed as a more rigorous and commercially significant credential in enterprise healthcare technology procurement.

The company did not provide a timeline for SOC 2 Type II certification. The announcement cautions that achieving this certification on schedule is not guaranteed, representing a material risk factor. Investors monitoring the compliance path may view this next phase as a sign of management’s commitment to enterprise-grade security, while acknowledging timing and outcomes remain uncertain.

Regulatory and Competitive Landscape for Digital Health Data Security

As healthcare systems increasingly adopt cloud-based technologies, demonstrated data security and regulatory compliance have become standard prerequisites for technology adoption. This aligns with industry dynamics in Canada and the U.S., where healthcare data is governed by stringent privacy laws such as Canada’s Personal Information Protection and Electronic Documents Act (PIPEDA), provincial health privacy statutes, and the U.S. Health Insurance Portability and Accountability Act (HIPAA).

For digital health companies competing for enterprise contracts, compliance with recognized third-party frameworks like SOC 2 has shifted from a differentiator to a baseline requirement. Rocket Doctor’s achievement reflects this reality, positioning the certification as both a competitive necessity and validation of existing practices. The company’s strategy to serve underserved and rural Canadian communities, alongside Medicaid and Medicare patients in the U.S., adds regulatory complexity that this compliance framework addresses.

Platform Scale and the Importance of the Global Library of Medicine

Rocket Doctor’s digital health platform and marketplace has facilitated over 350 physicians delivering care through more than 750,000 patient visits. The platform empowers physicians to independently launch and manage virtual or hybrid in-person practices, aiming to improve efficiency, restore physician autonomy, and expand patient access.

A key technology component is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide. The GLM serves as a cornerstone of Rocket Doctor AI’s technology offering, underpinning the company’s enterprise growth strategy now reinforced by the new security certification.

North American Expansion and Focus on Underserved Communities

Rocket Doctor AI reiterates its strategic commitment to expanding healthcare services across North America, focusing on underserved, rural, and remote Canadian communities lacking family doctors, as well as Medicaid and Medicare patients in the U.S. These markets are significant given the stringent data protection requirements imposed by Canadian provincial health authorities and U.S. federal programs.

By securing SOC 2 Type I certification, Rocket Doctor positions itself to meet procurement and compliance standards required by public-sector and government health programs. The announcement highlights government partners as key stakeholders benefiting from this independent assurance. Investors may anticipate future announcements of government-affiliated or public health system contracts as the enterprise strategy evolves.

Market Reaction and Share Price Impact

The immediate effect of the SOC 2 Type I compliance announcement on Rocket Doctor AI’s share price was not evident at the time of publication. The announcement was made on July 14, 2026, with the company listed on the Canadian Securities Exchange under ticker AIDR, OTC Markets under AIRDF, and Frankfurt Stock Exchange under symbol 939.

Compliance announcements in the digital health sector often bolster investor confidence by removing barriers to enterprise contracts. However, investors should recognize that certification does not guarantee revenue growth, new partnerships, or improved operating results. The company’s cautionary statements emphasize that actual outcomes may differ materially from forward-looking statements contained in the release.